AIDS WEEKLY Plus - February - 1999Important note: Information in this article was accurate in February 1999. The state of the art may have changed since the publication date.
Click here to return to AIDS WEEKLY PLUS main menu

Conference Coverage (Retrovirus) Inner-City Patients Not Taking HAART

AIDSWEEKLY Plus; Monday, February 22, 1999
Daniel J. DeNoon, Senior Editor


The revolution in AIDS care appears to have missed the inner city.

Since March 1996, highly active antiretroviral therapy (HAART) regimens have been available to inner-city residents of Atlanta, Georgia, at an outpatient clinic that is part of the Grady Health System. But after discharge from Grady Hospital, fewer than 15 percent of these patients have visited the outpatient clinic or received HAART.

Unsurprisingly, given such data, this population has seen no reduction in hospitalizations or opportunistic infections from 1994 through 1997.

"This study demonstrates that most HIV patients in the inner city do not take advantage of the very effective therapies that are available to them," said Carlos del Rio of Emory University, Atlanta, Georgia.

Del Rio presented the findings at the 6th Conference on Retroviruses and Opportunistic Infections, held January 31-February 4, 1999, in Chicago, Illinois.

The outpatient clinic is staffed by Emory faculty and offers access to highly trained primary care providers, oral and mental health services, and case-management and housing assistance.

As of December 1997, more than 1,000 patients had been prescribed HAART at the clinic. But this treatment-compliant group apparently represents only the tip of the patient iceberg.

"Although HAART has caused a dramatic decrease in AIDS-associated mortality and hospitalizations, for inner-city populations in particular, additional resources need to be allocated to get these patients into outpatient care."

990222
AW990218


Copyright © 1999 - Charles Henderson, Publisher. All rights Reserved. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633-4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX: (205) 995-1588 http://www.newsrx.net

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990, 2000. AEGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ĘGIS, or the party credited as the provider of the content.